Related references
Note: Only part of the references are listed.The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Robert Hermann et al.
CLINICAL PHARMACOKINETICS (2019)
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis
Robert Hoepner et al.
ACTA NEUROPATHOLOGICA (2019)
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects
Luisa Klotz et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis
Silvia Tietz et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Polymorphisms of the Multidrug Pump ABCG2: A Systematic Review of Their Effect on Protein Expression, Function, and Drug Pharmacokinetics
Niall Heyes et al.
DRUG METABOLISM AND DISPOSITION (2018)
Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states
Ioannis Manolaridis et al.
NATURE (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease
Charbel Moussa et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience
Aaron E. Miller
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2017)
Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives
Patricia K. Coyle
MULTIPLE SCLEROSIS INTERNATIONAL (2017)
In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia
Tanja Wostradowski et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide
Aziz Filali-Ansary et al.
THERAPEUTIC DRUG MONITORING (2016)
Toxicity of teriflunomide in aryl hydrocarbon receptor deficient mice
Chiara Redaelli et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Hisham Qosa et al.
BRAIN RESEARCH (2015)
Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor
Akimasa Seno et al.
EXPERIMENTAL ANIMALS (2015)
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis
Steffi Grey (nee Cotte) et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis
Michael D. Wiese et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
Li Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
ABC transporter function and regulation at the blood-spinal cord barrier
Christopher R. Campos et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Apolipoprotein-E Controls Adenosine Triphosphate-Binding Cassette Transporters ABCB1 and ABCC1 on Cerebral Microvessels After Methamphetamine Intoxication
Ayman ElAli et al.
STROKE (2012)
The role of ATP-binding cassette transporters in neuro-inflammation: relevance for bioactive lipids
Gijs Kooij et al.
FRONTIERS IN PHARMACOLOGY (2012)
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance
E. Kis et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis
S. Cotte et al.
BRAIN (2009)
In Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination
Jean E. Merrill
NEUROPSYCHOPHARMACOLOGY (2009)
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk
JW Jonker et al.
NATURE MEDICINE (2005)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)